OBJECTIVE: To compare cognitive impairments in dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD), to discriminate between the two entities. METHODS: 10 DLB and 12 PDD consecutive patients performed a neuropsychological battery designed to assess several cognitive domains: verbal and visual memory (Delayed Matching to Sample (DMS)-48), language, gnosia, praxia and executive functions. RESULTS: DLB patients had poorer performances in orientation (p<0.05), Trail Making Test A (p<0.05) and reading of names of colours in the Stroop Test (p<0.05). Their scores were also lower in the visual object recognition memory test (DMS-48), in both immediate (p<0.05) and delayed recognition (p<0.05). No differences were observed in the other tests. CONCLUSION: Despite global similarities in cognitive performances between DLB and PDD patients, we observed important differences: in particular, DMS-48, a test of visual object recognition memory and visual storage capacity, was poorer in DLB patients.
OBJECTIVE: To compare cognitive impairments in dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD), to discriminate between the two entities. METHODS: 10 DLB and 12 PDD consecutive patients performed a neuropsychological battery designed to assess several cognitive domains: verbal and visual memory (Delayed Matching to Sample (DMS)-48), language, gnosia, praxia and executive functions. RESULTS: DLB patients had poorer performances in orientation (p<0.05), Trail Making Test A (p<0.05) and reading of names of colours in the Stroop Test (p<0.05). Their scores were also lower in the visual object recognition memory test (DMS-48), in both immediate (p<0.05) and delayed recognition (p<0.05). No differences were observed in the other tests. CONCLUSION: Despite global similarities in cognitive performances between DLB and PDDpatients, we observed important differences: in particular, DMS-48, a test of visual object recognition memory and visual storage capacity, was poorer in DLB patients.
Authors: C G Ballard; D Aarsland; I McKeith; J O'Brien; A Gray; F Cormack; D Burn; T Cassidy; R Starfeldt; J-P Larsen; R Brown; M Tovee Journal: Neurology Date: 2002-12-10 Impact factor: 9.910
Authors: C Ballard; J O'Brien; A Gray; F Cormack; G Ayre; E Rowan; P Thompson; R Bucks; I McKeith; M Walker; M Tovee Journal: Arch Neurol Date: 2001-06
Authors: John Joseph Downes; Nicholas M. Priestley; Mark Doran; Jose Ferran; Eric Ghadiali; Paul Cooper Journal: Behav Neurol Date: 1998 Impact factor: 3.342
Authors: D Aarsland; I Litvan; D Salmon; D Galasko; T Wentzel-Larsen; J P Larsen Journal: J Neurol Neurosurg Psychiatry Date: 2003-09 Impact factor: 10.154
Authors: Joseph R Phillips; Elie Matar; Kaylena A Ehgoetz Martens; Ahmed A Moustafa; Glenda M Halliday; Simon J G Lewis Journal: Mov Disord Clin Pract Date: 2022-06-13
Authors: G A Jicha; F A Schmitt; E Abner; P T Nelson; G E Cooper; C D Smith; W R Markesbery Journal: Neurobiol Aging Date: 2008-11-20 Impact factor: 4.673
Authors: A Dhanushkodi; E O Akano; E E Roguski; Y Xue; S K Rao; S G Matta; T S Rex; M P McDonald Journal: Genes Brain Behav Date: 2012-11-28 Impact factor: 3.449
Authors: Daniel Roquet; Marion Sourty; Anne Botzung; Jean-Paul Armspach; Frédéric Blanc Journal: Alzheimers Res Ther Date: 2016-07-12 Impact factor: 6.982
Authors: Luis R Peraza; Sean J Colloby; Michael J Firbank; G Shirmin Greasy; Ian G McKeith; Marcus Kaiser; John O'Brien; John-Paul Taylor Journal: Int J Geriatr Psychiatry Date: 2015-08-13 Impact factor: 3.485
Authors: Denis S Smirnov; Douglas Galasko; Steven D Edland; J Vincent Filoteo; Lawrence A Hansen; David P Salmon Journal: Neurology Date: 2020-04-24 Impact factor: 11.800